# Leflunomide

## Arheuma 10mg

| TAH Drug Code      | [OARH1](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OARH1)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of rheumatoid arthritis (RA) and psoriatic arthritis in adults.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Dosing             | Adult loading dose 100 mg once daily for 3 days. Maintenance dose rheumatoid arthritis 10-20 mg once daily, psoriatic arthritis 20 mg once daily.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Contraindicated in patients with hypersensitivity to Leflunomide and its active metabolite A771726 (Teriflunomide), especially those with a history of Stevens-Johnson syndrome, toxic epidermal necrolysis, and erythema multiforme. Patients with hepatic impairment. Patients with severe immune system deficiency, such as AIDS. Patients with significant bone marrow dysfunction or hematological abnormalities not due to rheumatoid arthritis or psoriatic arthritis. Patients with severe infections. Patients with moderate to severe renal impairment. Patients with severe hypoproteinemia, such as nephrotic syndrome. Pregnancy. Lactation. Male patients should use effective contraception during treatment, as the drug may cause male-mediated fetal toxicity. Not recommended for use in patients under 18 years of age. |
| Adverse Effects    | Common: Alopecia (9-17%), Rash (10-12%), Diarrhea (17-27%), Ulcer of mouth (3-5%), Dizziness (4-7%), Headache (7-13%) Serious: Stevens-Johnson syndrome, Toxic epidermal necrolysis, Agranulocytosis, Pancytopenia, Thrombocytopenia, ALT/SGPT level raised (1.5-4.4%), Hepatic necrosis, Injury of liver, Liver failure, Anaphylaxis, Drug reaction with eosinophilia and systemic symptoms, Infectious disease, Opportunistic infection, Tuberculosis, Peripheral neuropathy, Interstitial lung disease, Pneumocystis pneumonia, Respiratory tract infection (10% or greater)                                                                                                                                                                                                                                                             |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/leflunomide-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |

